Sorry, there are no transactions available for this individual.
EyePoint Pharmaceuticals Inc.
NAS: EYPT
/marketstate/country/us
/zigman2/quotes/210537129/composite
After Hours
--Quotes are delayed by 20 min
Nov 30, 2023, 5:25 p.m.
$
6.56
Change
+0.31 +4.96%
Volume
Volume 3,010
Quotes are delayed by 20 min
/zigman2/quotes/210537129/composite
Previous close
$ 6.28
$ 6.25
Change
-0.03 -0.48%
Day low
Day high
$6.23
$6.61
52 week low
52 week high
$2.19
$15.63
Officers and Executives
|
Dr. Jay S. Duker President, Chief Executive Officer & Director |
|
Mr. George O. Elston Chief Financial Officer & Executive Vice President |
|
Dr. Said Saim Chief Technology Officer |
|
Dr. Dario A. Paggiarino Chief Medical Officer & Senior Vice President |
|
Ms. Jennifer Leonard Chief People Officer & Senior Vice President-IT |
|
Mr. Scott Jones Chief Commercial Officer & Senior Vice President |
|
Mr. Michael C. Pine Chief Corporate Development & Strategy Officer |
|
Mr. Ye Liu Director |
|
Mr. Stuart Duty Director |
|
Mr. Ron I. Honig Secretary, Chief Legal Officer & Senior VP |
|
Ms. Isabelle Lefebvre Chief Regulatory Officer |
|
Dr. G?ran Albert Torstensson Ando Non-Executive Chairman |
|
Ms. Wendy F. DiCicco Independent Director |
|
Dr. Anthony P. Adamis Independent Director |
|
Ms. Karen L. Zaderej Independent Director |
|
Dr. John Barry Landis Independent Director |
|
Dr. David R. Guyer Independent Director |
Log In
7:35 AM EST
December 1, 2023
/marketstate/country/us
New York
Pre
/marketstate/country/uk
London
Open
/marketstate/country/jp
Tokyo
Closed
/marketstate/country/us
/marketstate/country/uk
/marketstate/country/jp
Latest News
-
/news/latest
-
Pfizer’s stock falls 4% after halting trial of obesity drug due to side effects
-
Pfizer's Weight Loss Drug Won't Enter a Phase 3 Trial. The Stock Drops.
-
Who says corporate bonds are dull? Apple’s bonds have seen equity-like returns in the past month
-
Brookfield Asset Management raises $30 billion for private infrastructure investments
-
Fisker Slashes Production Guidance Again. So Why Is the Stock Rising?
-
Bitcoin Rallies to 19-Month Highs. Will It Hold Above $38,000 This Time?
-
Tesla’s stock heads for 3rd straight loss in wake of Cybertruck launch
-
Bill Gross says beaten-down mortgage plays may thrive — and offer huge yields
-
‘Tis the season — for scams. What older Americans need to watch out for this month.
-
How Golden Bachelor came to an end: a golden rose and broken hearts
-
Russia wrests control of St. Petersburg airport from German and Qatari investors: report
-
Spirit AeroSystems started at hold with $28 stock price target at Stifel
-
TransDigm started at hold with $1,000 stock price target at Stifel
-
Boeing started at buy with $265 stock price target at Stifel
-
AAR Corp. started at buy with $80 stock price target at Stifel
- Loading more headlines...
Kiosk
-
13203972000001320598500000310238
Alerts
-
13337034000001333949700000310284
Virtual Stock Exchange
Our free stock-market game
• Trade your virtual portfolio in real time
• Talk strategies in group discussions
• Find or create a game that suits you
• Use our learning center to improve
Copyright © 2023 MarketWatch, Inc. All rights reserved.
Subscriber Agreement & Terms of Use |
Privacy Notice |
Cookie Notice
Intraday Data provided by FACTSET and subject to terms of use. Historical and current end-of-day data provided by FACTSET. All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements.